Spyre Therapeutics (SYRE) P/E (2016 - 2026)
Spyre Therapeutics (SYRE) P/E from Jun 30, 2016 to Jul 21, 2026. The TTM Spyre Therapeutics (SYRE) P/E is -41.61. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/E
Annual P/E change of Spyre Therapeutics (SYRE)
| Year | P/E | Change |
|---|---|---|
| 2026 | -41.61 | +196.67% |
| 2025 | -14.03 | +116.12% |
| 2024 | -6.49 | -62.88% |
| 2023 | -17.48 | +144.06% |
| 2022 | -7.16 | -91.93% |
| 2021 | -88.80 | -9.74% |
| 2020 | -98.38 | +39.32% |
| 2019 | -70.62 | -21.96% |
| 2018 | -90.49 | +17.31% |
| 2017 | -77.14 | -38.33% |
| 2016 | -125.08 | N/A |
Comparison Spyre Therapeutics (SYRE) P/E with competitors
Spyre Therapeutics (SYRE) P/E is -41.61.